OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD?
Nermin Eissa, Adel Sadeq, Astrid Sasse, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Curcumin Potentiates α7 Nicotinic Acetylcholine Receptors and Alleviates Autistic-Like Social Deficits and Brain Oxidative Stress Status in Mice
Petrilla Jayaprakash, Dmytro Isaev, Waheed Shabbir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7251-7251
Open Access | Times Cited: 22

Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities
Ali Saad, Amal Akour, Abdulla Mahboob, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 612-612
Open Access | Times Cited: 15

Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia
Yaiza M. Arenas, Mar Martinez‐García, Marta Llansola, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11770-11770
Open Access | Times Cited: 15

Developmental pyrethroid exposure and age influence phenotypes in a Chd8 haploinsufficient autism mouse model
Jessica A. Jiménez, Jeremy M. Simon, Wenxin Hu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14

Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia
Eelis Hyvärinen, Eino Solje, Jouko Vepsäläinen, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 233-233
Open Access | Times Cited: 8

Interaction of Heavy Metal Lead with Gut Microbiota: Implications for Autism Spectrum Disorder
Yousef Tizabi, Samia Bennani, Nacer El Kouhen, et al.
(2023)
Open Access | Times Cited: 7

Pharmacological modulation of HIF-1 in the treatment of neuropsychiatric disorders
Diksha Sharma, Heena Khan, Amit Kumar, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 12, pp. 1523-1535
Closed Access | Times Cited: 7

Tackling Neuroinflammation in Cognitive Disorders with Single-Targeted and Multi-Targeted Histamine H3 Receptor Modulators
Flávia B. Lopes, João Paulo S. Fernandes, Elisa Uliassi
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 28, pp. 2421-2430
Closed Access | Times Cited: 2

Taurine inhibits KDM3a production and microglia activation in lipopolysaccharide-treated mice and BV-2 cells
K. Liu, Runying Zhu, Hongwei� Jiang, et al.
Molecular and Cellular Neuroscience (2022) Vol. 122, pp. 103759-103759
Closed Access | Times Cited: 11

The Roles of Histamine Receptor 1 (hrh1) in Neurotransmitter System Regulation, Behavior, and Neurogenesis in Zebrafish
Yuxiao Yao, Diego Baronio, Yu‐Chia Chen, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6660-6675
Open Access | Times Cited: 5

Taurine as a potential therapeutic agent interacting with multiple signaling pathways implicated in autism spectrum disorder (ASD): An in-silico analysis
Ranjana Bhandari, Manasi Varma, Priyanka Rana, et al.
IBRO Neuroscience Reports (2023) Vol. 15, pp. 170-177
Open Access | Times Cited: 5

On the Potential Therapeutic Roles of Taurine in Autism Spectrum Disorder
Alberto Rubio‐Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
Neuroglia (2022) Vol. 4, Iss. 1, pp. 1-14
Open Access | Times Cited: 8

Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice
Nermin Eissa, M. Awad, Shilu Deepa Thomas, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 526-526
Open Access | Times Cited: 8

Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus – A Register-based Study
Helena Kullenberg, Moa Wibom, Maria Kumlin, et al.
Current Alzheimer Research (2023) Vol. 20, Iss. 2, pp. 109-119
Closed Access | Times Cited: 4

Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1‐deficient mice
Danielle Santana‐Coelho, Samantha L. Hodges, Saul I. Quintero, et al.
Brain and Behavior (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 4

Link between the skin and autism spectrum disorder
Mao‐Qiang Man, Shuyun Yang, Theodora M. Mauro, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4

Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders
Olayemi K. Ijomone, Rademene Sunday Oria, Omamuyovwi M. Ijomone, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1

Histaminergic System Activity in the Central Nervous System: The Role in Neurodevelopmental and Neurodegenerative Disorders
Dariusz Szukiewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9859-9859
Open Access | Times Cited: 1

Identification of key genes and convergent pathways disrupted in autism spectrum disorder via comprehensive bioinformatic analysis
Maryam Rahnama, Hossein Abdul Tehrani, Mehdi Mirzaie, et al.
Informatics in Medicine Unlocked (2021) Vol. 24, pp. 100589-100589
Open Access | Times Cited: 10

Peripheral Expression of ADORA2A Is Increased and Is Correlated with Autism Spectrum Disorder Severity in a Sample of Turkish Children
Hilal Akköprü, Alper Alnak, Zeynep Nur Karadoğan, et al.
Psychiatry and Clinical Psychopharmacology (2023) Vol. 33, Iss. 1, pp. 14-19
Open Access | Times Cited: 3

Higher Levels of Galectin-1 and Galectin-3 in Young Subjects with Autism Spectrum Disorder Compared to Unaffected Siblings and Healthy Controls
Zeynep Nur Karadoğan, Yaşar Tanır, Ali Karayağmurlu, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 4, pp. 749-757
Open Access | Times Cited: 3

Insights into the advances in therapeutic drugs for neuroinflammation-related diseases
B. Luo
International Journal of Neuroscience (2023), pp. 1-26
Closed Access | Times Cited: 3

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
David M. Hough, Alice R. Mao, Michael G. Aman, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Scroll to top